However, the relationship between the infiltration level of CD103+CD8+ TRMs and clinicopathological characteristics and prognosis of CRC, and the potential for clinical applications of CD103+CD8+ TRMs remains unclear. The gene discussed is ITGAE; the disease is colorectal carcinoma.